Evidence map›Paper›PMID 34801527›Full record

ArticleThe Journal of infection2022

Quantification and prognostic significance of interferon-γ secreting SARS-CoV-2 responsive T cells in hospitalized patients with acute COVID-19.

Daniel Pan, Jee Whang Kim, Joshua Nazareth, Sara Assadi, Adam Bellass, Jack Leach, James G Brosnan, Adam Ahmed, Fleur Starcevic, Shirley Sze and 9 more

Abstract readLetterComment
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Daniel PanDepartment of Respiratory Sciences, University of Leicester, United Kingdom; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom. Electronic address: daniel.pan@nhs.net.
Jee Whang KimDepartment of Respiratory Sciences, University of Leicester, United Kingdom; Respiratory Biomedical Research Center, University of Leicester, United Kingdom.
Joshua NazarethDepartment of Respiratory Sciences, University of Leicester, United Kingdom; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom.
Sara AssadiDepartment of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom.
Adam BellassDepartment of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom.
Jack LeachUniversity of Leicester Medical School, United Kingdom.
James G BrosnanUniversity of Leicester Medical School, United Kingdom.
Adam AhmedUniversity of Leicester Medical School, United Kingdom.
Fleur StarcevicDepartment of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom.
Shirley SzeDepartment of Cardiovascular Sciences, University of Leicester, United Kingdom.
Christopher A MartinDepartment of Respiratory Sciences, University of Leicester, United Kingdom; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom.
Caroline M WilliamsDepartment of Respiratory Sciences, University of Leicester, United Kingdom; Department of Microbiology, University Hospitals of Leicester NHS Trust, United Kingdom.
Michael R BarerDepartment of Respiratory Sciences, University of Leicester, United Kingdom; Department of Microbiology, University Hospitals of Leicester NHS Trust, United Kingdom.
Amandip SahotaDepartment of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom.
Prashanth PatelDepartment of Chemical and Metabolic Diseases, University Hospitals of Leicester NHS Trust, United Kingdom.
Andrea TattersallOxford Immunotec Ltd, United Kingdom.
Andrea CooperDepartment of Respiratory Sciences, University of Leicester, United Kingdom; Trudeau Institute, Saranac Lake, New York, USA.
Manish PareekDepartment of Respiratory Sciences, University of Leicester, United Kingdom; Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom.
Pranabashis HaldarDepartment of Respiratory Sciences, University of Leicester, United Kingdom; Respiratory Biomedical Research Center, University of Leicester, United Kingdom.

Funding

Medical Research Council MR/P023061/1Medical Research Council MR/S002278/1Medical Research Council MR/V027549/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HIV InfectionsAntibodies, ViralHumansImmunity, HumoralInterferon-gammaPrognosisSARS-CoV-2Spike Glycoprotein, CoronavirusT-LymphocytesAntibodies, ViralInterferon-gammaSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID34801527
PMCPMC8603398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.